Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 4, Pages 2056
Publisher
MDPI AG
Online
2021-02-19
DOI
10.3390/ijms22042056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial Protection by PARP Inhibition
- (2020) Ferenc Gallyas Jr et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
- (2020) Ningni Jiang et al. MOLECULAR BIOLOGY REPORTS
- Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics—A Review
- (2020) Jelena S. Katanic Stankovic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers
- (2019) Patrick G. Pilié et al. CLINICAL CANCER RESEARCH
- PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells
- (2019) Anna Maria Cseh et al. Frontiers in Physiology
- Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- (2019) Rasha M. Sareyeldin et al. Cancers
- Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors
- (2019) Mattia Garutti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy of PI3K inhibitors in advanced breast cancer
- (2019) B Verret et al. ANNALS OF ONCOLOGY
- Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis
- (2019) Inês Godet et al. Nature Communications
- PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside
- (2018) Anita A. Turk et al. CANCER
- Antitumor effects and mechanisms of olaparib in combination with carboplatin and BKM120 on human triple‑negative breast cancer cells
- (2018) Hui Zhao et al. ONCOLOGY REPORTS
- Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer
- (2017) Jung-Min Lee et al. Oncotarget
- The PI3K Pathway: Background and Treatment Approaches
- (2016) Michael P. Lux et al. Breast Care
- Triple-negative breast cancer: is there a treatment on the horizon?
- (2016) Hui Yao et al. Oncotarget
- Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
- (2016) Xiaofeng Dai et al. Journal of Cancer
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer
- (2013) Judith Michels et al. CELL CYCLE
- Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
- (2013) Julio Morales et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration
- (2012) Angela Ogden et al. CANCER AND METASTASIS REVIEWS
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation
- (2012) Yasuo Imai ONCOLOGY REPORTS
- Transition probability in cell proliferation, stochasticity in cell differentiation, and the restriction point of the cell cycle in one package
- (2012) A. Golubev PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells
- (2010) El-Shaimaa A. Arafa et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now